ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 115 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $12,387,298 | -2.1% | 3,742,386 | -3.3% | 0.00% | – |
Q1 2024 | $12,651,888 | -8.2% | 3,869,079 | -1.5% | 0.00% | – |
Q4 2023 | $13,785,866 | -35.3% | 3,927,597 | +23.2% | 0.00% | -100.0% |
Q3 2023 | $21,291,966 | -20.2% | 3,187,420 | +0.2% | 0.00% | 0.0% |
Q2 2023 | $26,681,827 | +7.5% | 3,180,194 | +27.3% | 0.00% | 0.0% |
Q1 2023 | $24,816,669 | +43.1% | 2,499,161 | +0.3% | 0.00% | – |
Q4 2022 | $17,346,193 | +29.1% | 2,492,269 | -0.9% | 0.00% | – |
Q3 2022 | $13,434,000 | +38.2% | 2,515,884 | +3.2% | 0.00% | – |
Q2 2022 | $9,723,000 | -26.1% | 2,436,758 | -17.7% | 0.00% | – |
Q1 2022 | $13,165,000 | +17.0% | 2,961,635 | +5.2% | 0.00% | – |
Q4 2021 | $11,256,000 | -53.0% | 2,813,924 | +3.2% | 0.00% | -100.0% |
Q3 2021 | $23,947,000 | -21.6% | 2,727,396 | +1.1% | 0.00% | 0.0% |
Q2 2021 | $30,551,000 | +25.3% | 2,696,450 | +31.4% | 0.00% | 0.0% |
Q1 2021 | $24,384,000 | +120.0% | 2,052,495 | +27.0% | 0.00% | – |
Q4 2020 | $11,086,000 | -9.4% | 1,616,005 | -2.2% | 0.00% | – |
Q3 2020 | $12,239,000 | +184.2% | 1,651,758 | +59.9% | 0.00% | – |
Q2 2020 | $4,307,000 | +54.8% | 1,032,971 | -8.3% | 0.00% | – |
Q1 2020 | $2,783,000 | -57.4% | 1,126,642 | +0.1% | 0.00% | – |
Q4 2019 | $6,538,000 | +9.9% | 1,125,332 | -0.3% | 0.00% | – |
Q3 2019 | $5,948,000 | -10.8% | 1,128,617 | +1.5% | 0.00% | – |
Q2 2019 | $6,671,000 | -30.9% | 1,111,944 | +4.0% | 0.00% | – |
Q1 2019 | $9,654,000 | +5.8% | 1,069,075 | -2.8% | 0.00% | – |
Q4 2018 | $9,127,000 | -30.2% | 1,099,620 | +16.0% | 0.00% | -100.0% |
Q3 2018 | $13,081,000 | +118.2% | 947,876 | +25.7% | 0.00% | – |
Q2 2018 | $5,995,000 | +14.6% | 754,169 | +8.1% | 0.00% | – |
Q1 2018 | $5,232,000 | +10.1% | 697,634 | -0.1% | 0.00% | – |
Q4 2017 | $4,750,000 | +40.0% | 698,534 | +48.3% | 0.00% | – |
Q3 2017 | $3,392,000 | +137.0% | 471,031 | +54.6% | 0.00% | – |
Q2 2017 | $1,431,000 | -3.0% | 304,633 | +3.2% | 0.00% | – |
Q1 2017 | $1,476,000 | +89.5% | 295,226 | +102.9% | 0.00% | – |
Q4 2016 | $779,000 | -25.3% | 145,472 | +9.5% | 0.00% | – |
Q3 2016 | $1,043,000 | +46.5% | 132,886 | +6.2% | 0.00% | – |
Q2 2016 | $712,000 | +40.2% | 125,125 | +3.1% | 0.00% | – |
Q1 2016 | $508,000 | -36.7% | 121,407 | +2.6% | 0.00% | – |
Q4 2015 | $802,000 | -99.6% | 118,340 | -97.6% | 0.00% | -100.0% |
Q3 2015 | $186,567,000 | +23162.7% | 4,869,794 | +4606.5% | 0.01% | – |
Q2 2015 | $802,000 | – | 103,470 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,155,300 | $4,621,000 | 2.77% |
Knoll Capital Management, LLC | 759,405 | $3,038,000 | 1.67% |
ACUTA CAPITAL PARTNERS, LLC | 500,000 | $2,000,000 | 0.84% |
Perceptive Advisors | 19,807,758 | $79,232,000 | 0.61% |
Mesirow Financial Investment Management, Inc. | 48,711 | $195,000 | 0.56% |
Ghost Tree Capital, LLC | 300,000 | $1,200,000 | 0.43% |
Stonepine Capital Management, LLC | 200,000 | $800,000 | 0.37% |
APOGEM CAPITAL LLC | 86,730 | $347,000 | 0.23% |
JOHNSON & JOHNSON | 394,834 | $1,579,000 | 0.18% |
Affinity Asset Advisors, LLC | 100,759 | $403,000 | 0.15% |